The federal government will investigate UnitedHealth Group following the Change Healthcare cyber attack. Diabetes and weight loss drug Ozempic was found to delay the progression of chronic kidney disease in diabetic patients, according to a large-scale clinical trial. And, drugmaker Eli Lilly partners with Amazon to deliver its weight loss drug Zepbound, directly to consumers’ homes. That’s coming up on today’s episode of Gist Healthcare Daily.
Hosted on Acast. See acast.com/privacy for more information.
